
Executive Steering Committee








Flavia-D'Souza
Enabling Platforms
Flavia D’Souza is the Co-Founder of Sentio BioSciences, a FDA registered development and cGMP manufacturing small business, where she has served as Head of Quality for over 10 years. While leading Sentio’s quality and regulatory affairs, Flavia has developed a deep understanding of the regulatory environment and taken two drug products from development to FDA approval and commercial manufacturing. As new platforms and technologies for Manufacturing Drug Substance and Drug...

Melissa Berquist
Drug Substance Manufacturing
Melissa Berquist currently serves as the Senior Director of Strategy & Execution, and Chief of Staff, for FUJIFILM Diosynth Biotechnologies Texas (FDB Texas), an industry leading CDMO. Prior to joining FDB Texas, Melissa served in senior leadership roles at a number of biotechnology firms and has nearly 20 years of experience in the Biodefense sector, leading organizations monitoring and researching public health threats, then identifying and manufacturing countermeasures. Melissa has...

Helen Bush
Logistics & Supply Chain
Helen Bush is a seasoned Supply Chain and Logistics Director with over twenty years of experience driving operational excellence and strategic innovation in global supply chain management. During her tenure at UPS and Evonik Corp, Helen has developed proven expertise in data analytics, enhancing efficiencies and reducing costs in competitive environments. She is skilled at ensuring seamless coordination across procurement, production, and distribution channels, with a strong focus on problem-solving...

Sean Kirk
Commercial Scale Manufacturing
Sean Kirk is a Global Strategic Healthcare Operations Executive with significant multi-disciplinary experience, diverse financial and business acumen, corporate governance experience, and a track record of increasing responsibility. Currently he serves as the Principal for Arena BioPharma Consulting, LLC, an executive consultant services provider in the life science industry. Previously, Sean dedicated 18+ years of focused effort, and played a key role in driving the expansion of Emergent BioSolutions (NYSE:...

David Powell
Delivery Devices
Dave has worked in the pharmaceutical industry for over 30 years, mostly in roles and companies in the CDMO industry. The majority of his experience is in the fill-and-finish segment of the industry, from early days as an engineer in operations to an executive role in a leading CDMO. He has been a member of the industry trade organization Pharma & Biopharma Outsourcing Association (PBOA) since its inception in 2014,...

Peter Stolba
Critical Infrastructure
Peter Stolba is the Chief Business Officer (CBO) at Artis Biosolutions, bringing extensive experience in business operations and development across the pharmaceutical industry. Before joining Artis Biosolutions, Peter was Vice President of Business Development at Halozyme and previously served as Vice President of Business Operations at TriLink Biotechnologies / Maravai LifeSciences, where he played a key role during a transformative growth phase that included advancing nucleic acid technologies and contributing...

Whitney Tull
Sterilization
Whitney Tull joined STERIS in April 2019 to lead Government Affairs for the Company. In this role, she coordinates external engagement with a broad set of stakeholders comprising of associations, government officials, policy makers, and Customers for STERIS. Additionally, Whitney serves on STERIS’s Senior Management Team (SMT) and sits on the Ohio Life Sciences Board of Directors. Prior to joining STERIS, she managed U.S. Government Affairs for 11 years at...

John Clapham
Drug Product & Fill/Finish
John Clapham is CEO of PSC Biotech Corporation, PSC Software, BioTechnique, and Future Cures. He is the Founder of PSC Biotech Corporation and has been with the Company since founding the Company in 1996. John is a graduate of the University of Rhode Island, with a bachelor’s degree in chemical engineering in 1989. He has done graduate studies at the University of New Haven. He has worked for the United...
